BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| xylooligosaccharide - Bifidobacterium stercoris |
👶
Effects of Xylo-Oligosaccharide on the Gut Microbiota of Patients With Ulcerative Colitis in Clinical Remission. Frontiers in nutrition (Front Nutr ) Vol: 8 Issue Pages: 778542 Pub: 2021 Epub: 2021 Dec 28 Authors Li Z , Li Z , Zhu L , Dai N , Sun G , Peng L , Wang X , Yang Y , Html Article Publication |
| xylooligosaccharide - Bifidobacterium stercoris |
👶
Dietary xylo-oligosaccharide stimulates intestinal bifidobacteria and lactobacilli but has limited effect on intestinal integrity in rats. BMC research notes (BMC Res Notes ) Vol: 7 Issue Pages: 660 Pub: 2014 Sep 19 Epub: 2014 Sep 19 Authors Christensen EG , Licht TR , Leser TD , Bahl MI , Html Article Publication |
| xylooligosaccharide - Bifidobacterium stercoris |
👶
Research Note: Effect of dietary xylo-oligosaccharide on growth performance, intestinal histomorphology, and specific cecal bacteria in broiler chickens. Poultry science (Poult Sci ) Vol: 103 Issue 1 Pages: 103189 Pub: 2024 Jan Epub: 2023 Oct 17 Authors Yadav S , Singh AK , Selvaraj RK , Applegate TJ , Bhattacharya P , Shinall SB , Fenn LS , Shanmugasundaram R , Kim WK , Html Article Publication |
| xylooligosaccharide - Bifidobacterium stercoris |
👶
Similarities and differences of oligo/poly-saccharides' impact on human fecal microbiota identified by in vitro fermentation. Applied microbiology and biotechnology (Appl Microbiol Biotechnol ) Vol: 105 Issue 19 Pages: 7475-7486 Pub: 2021 Oct Epub: 2021 Sep 6 Authors Wang S , Zhang X , Li H , Ren Y , Geng Y , Lu Z , Shi J , Xu Z , Publication |
| xylooligosaccharide - Bifidobacterium stercoris |
👶
In vitro fermentability of xylo-oligosaccharide and xylo-polysaccharide fractions with different molecular weights by human faecal bacteria. Carbohydrate polymers (Carbohydr Polym ) Vol: 179 Issue Pages: 50-58 Pub: 2018 Jan 1 Epub: 2017 Sep 6 Authors Ho AL , Kosik O , Lovegrove A , Charalampopoulos D , Rastall RA , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
